Insights

Gathering insights about Molo…

Similar companies to Molo

Molo Tech Stack

Molo uses 8 technology products and services including Linkedin Insight Tag, Adobe Fonts, Vue.js, and more. Explore Molo's tech stack below.

Linkedin Insight Tag
Analytics
Adobe Fonts
Font Scripts
Vue.js
Javascript Frameworks
Amazon ALB
Load Balancers
Webpack
Miscellaneous
X-Content-Type-Options
Miscellaneous
X-XSS-Protection
Security
Envoy
Web And Application Servers

Media & News

Homology Medicines Declares Distribution to Common Stockholders
BEDFORD, Mass., March 18, 2024 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX) today announced that it declared a distribution to its common stockholders of record as of the close of business on March 21, 2024 of the right to receive one contingent value right (CVR) for each outstanding share of Homology common stock held by such stockholder as of such record date. The payment date for such distribution is expected to be March 27, 2024 (three business days after the expected closing of the merger on March 22, 2024). Each CVR represents the non-transferable contractual right to receive certain contingent payments upon the occurrence of certain events within agreed time periods as provided in the merger agreement and agreement governing the CVRs.
Mar 18, 2024 | www.globenewswire.com
HOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Homology Medicines, Inc. (NasdaqGS: FIXX) with Q32 Bio Inc. Under the terms of the proposed transaction, Homology shareholders will end up owning approximately 25% of the combined company, subject to possible adjustment. KSF is seeking to determine whether the merger and the process that led to it are adequa.
Feb 27, 2024 | www.businesswire.com
HOMOLOGY MEDICINES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX
NEW ORLEANS , Jan. 26, 2024 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
Jan 26, 2024 | www.prnewswire.com
Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency
Homology Medicines has an initial 180-day period through June 26, 2024 to regain compliance with Minimum Bid Price Requirement
Jan 03, 2024 | www.globenewswire.com
HOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Homology Medicines, Inc. (NasdaqGS: FIXX) with Q32 Bio Inc. Under the terms of the proposed transaction, Homology shareholders will end up owning approximately 25% of the combined company, subject to possible adjustment. KSF is seeking to determine whether the merger and the process that led to it are adequa.
Nov 17, 2023 | www.businesswire.com
FIXX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Homology Medicines, Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Homology Medicines, Inc. (NASDAQ: FIXX) and Q32 Bio Inc. is fair to Homology shareholders. Upon completion of the proposed transaction, Homology shareholders are expected to own approximately 25% of the combined company. Halper Sadeh encourages Homology shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763.
Nov 16, 2023 | www.businesswire.com
Q32 Bio and Homology Medicines Announce Merger Agreement
--The combined company will operate as Q32 Bio Inc., advancing the development of Q32 Bio's two clinical development candidates, bempikibart (ADX-914) in Phase 2 for the treatment of atopic dermatitis (AD) and alopecia areata (AA), and ADX-097 entering Phase 2 for the treatment of complement disorders-- --Q32 Bio has re-acquired worldwide development and commercial rights to bempikibart, an anti-IL-7Rα antibody inhibiting IL-7 and TSLP-mediated signaling, and remains on-track to report multiple topline Phase 2 results in 2H'24 -- --Concurrent $42 million private placement investment with new and existing investors supports clinical development through multiple milestones, including key Phase 2 readouts for bempikibart, initial ADX-097 proof-of-concept data by year-end 2024 and ADX-097 topline results in 2H'25 -- --Combined company's cash balance expected to be approximately $ 115 million at close, providing cash runway to mid-2026-- WALTHAM, Mass. and BEDFORD, Mass.
Nov 16, 2023 | www.prnewswire.com

Molo's Email Address Formats

Molo uses at least 1 format(s):

Molo Email Formats	Example	Percentage
First.Last@molofinance.com	John.Doe@molofinance.com	50%
First.Last@molofinance.com	John.Doe@molofinance.com	50%

Frequently Asked Questions

Where is Molo's headquarters located?

Molo's main headquarters is located at 84 Eccleston Square London, England GB. The company has employees across 5 continents, including EuropeAfricaAsia.

What is Molo's stock symbol?

Molo is a publicly traded company; the company's stock symbol is FIXX.

What is Molo's official website and social media links?

Molo's official website is molofinance.com and has social profiles on LinkedIn.

How much revenue does Molo generate?

As of January 2025, Molo's annual revenue reached $7.5M.

What is Molo's NAICS code?

Molo's NAICS code is 52 - Finance and Insurance.

How many employees does Molo have currently?

As of January 2025, Molo has approximately 53 employees across 5 continents, including EuropeAfricaAsia. Key team members include Chief Executive Officer: M. K.Chief Commercial Officer: M. M.Chief Technology Officer: N. R.. Explore Molo's employee directory with LeadIQ.

What industry does Molo belong to?

Molo operates in the Financial Services industry.

What technology does Molo use?

Molo's tech stack includes Linkedin Insight TagAdobe FontsVue.jsAmazon ALBWebpackX-Content-Type-OptionsX-XSS-ProtectionEnvoy.

What is Molo's email format?

Molo's email format typically follows the pattern of . Find more Molo email formats with LeadIQ.

How much funding has Molo raised to date?

As of January 2025, Molo has raised $8.6M in funding. The last funding round occurred on Oct 05, 2020 for $8.6M.

When was Molo founded?

Molo was founded in 2018.

Molo

Financial ServicesEngland, United Kingdom51-200 Employees

Molo is an award-winning fintech disrupting the mortgage industry. Since launching in 2018, we've led change in the UK mortgage market and have processed over £2 billion in mortgage applications submitted through our platform. 

Our goal is to overhaul the mortgage experience and bring it firmly in line with other modern, customer-centric financial services. With a tech-first approach, we deliver simpler, faster mortgage lending that replaces cumbersome processes with near real-time decisions.

We've won several awards for 'Best Digital Mortgage Lender' at the Fintech Awards and 'Best Online Mortgage Lender' at the Lending Awards. Molo is a wholly-owned subsidiary of ColCap Financial Limited and is regulated by the UK's Financial Conduct Authority.

Company Overview

Headquarters: 84 Eccleston Square London, England GB
Website: molofinance.com
Stock Symbol: FIXX
NAICS Code: 52 - Finance and Insurance
Founded: 2018
Employees: 51-200

Media & News

Funding & Financials

$8.6M
Molo has raised a total of $8.6M of funding over 4 rounds. Their latest funding round was raised on Oct 05, 2020 in the amount of $8.6M.
$10M
Molo's revenue is in the range of $10M

Funding & Financials

$8.6M
Molo has raised a total of $8.6M of funding over 4 rounds. Their latest funding round was raised on Oct 05, 2020 in the amount of $8.6M.
$10M
Molo's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Molo

Ladder

Hippo Insurance

Metromile

Next Insurance

Cover

Clearcover

Jetty

Kin Insurance

Lemonade

Bright Health

Embroker

Policygenius

Molo Tech Stack

Media & News

Homology Medicines Declares Distribution to Common Stockholders

HOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX

HOMOLOGY MEDICINES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX

Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency

HOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX

FIXX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Homology Medicines, Inc. Is Fair to Shareholders

Q32 Bio and Homology Medicines Announce Merger Agreement

Molo's Email Address Formats

Frequently Asked Questions

Where is Molo's headquarters located?

What is Molo's stock symbol?

What is Molo's official website and social media links?

How much revenue does Molo generate?

What is Molo's NAICS code?

How many employees does Molo have currently?

What industry does Molo belong to?

What technology does Molo use?

What is Molo's email format?

How much funding has Molo raised to date?

When was Molo founded?

Molo

Company Overview

Media & News

Homology Medicines Declares Distribution to Common Stockholders

HOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX

HOMOLOGY MEDICINES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?